Earnings call with investors on 29 Oct 2026 at noon for Q2 and H1FY27 results

Board & Shareholder Meetings View source PDF Explain this filing

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹990.00

prior close

₹985.60

announcement price

In-mkt

timing

Nifty Microcap 250market-2.6%+1.1% vs market

Specialty Chemicals peers, median of 100sector-3.3%+1.8% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.6

15m

-1.0

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-2.6+1.1-3.3+1.8

Next day

-3.1-3.6+0.5-4.3+1.2

-3.0-5.8+2.8-7.0+3.9

-0.4-5.5+5.1-6.6+6.2

+3.6pendingpending-5.5+9.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sudeep Pharma has scheduled an earnings call with analysts and investors on Thursday, 29 October 2026 at 12 noon IST. The management will discuss operational and financial results for Q2 and the half year ended 30 September 2026. MD Sujit Bhayani, Director Shanil Bhayani and CFO Ketan Vyas will represent the company. The call is hosted by 360 ONE CM Research. Dial-in numbers and registration link are attached.

Likely market impact

Routine intimation. Watch for management commentary on margins, growth outlook and guidance during the call.